AseBio

#NewAseBioMember | "AseBio is the perfect opportunity to participate in the ecosystem of Spanish biotech companies"

Meet NANODECAL, our new partner. We talked to its CEO, Roberto de la Rica.

Roberto_de_la_Rica_NANODECAL
AseBio
Healthcare
Innovative drugs

AseBio. What does your company's work bring to the table and what is its strength?

Roberto de la Rica. We are developing a new family of rapid tests for diagnosing respiratory diseases. Our strength lies in our patented technology, which allows us to overcome bottlenecks that were hindering progress in this field

AseBio. What is AseBio for you?

Roberto de la Rica. The perfect opportunity to make ourselves known and participate in the ecosystem of Spanish biotechnology companies.

AseBio. When did you first hear about AseBio?

Roberto de la Rica. In BIOSPAIN.

AseBio. What do you expect from being part of an association like AseBio?

Roberto de la Rica. To interact with other companies in the sector, build critical mass to drive new policies in the biotech industry, and gain national and international visibility.

AseBio. What is the biggest challenge facing the biotech sector (or your company)?

Roberto de la Rica. In our sector, the certification process to obtain the CE marking is one of the biggest challenges we have to face, given the current shortage of notified bodies.